Biological Information

Background Information:

The BioMAP Oncology Early Screening Service (StroHT29) is a high quantity screening format in BioMAP oncology system StroHT29, comprised of dermal fibroblasts, the HT-29 colorectal adenocarcinoma cell line, and peripheral blood mononuclear cells. This stromal TME model is stimulated via the T cell receptor for 48-hrs to recapitulate the activation of tumor infiltrating immune cells in the context of an immunosuppressive cancer cell line and normal host stromal tissue. Biomarker readouts capture impacts on translationally relevant immune, matrix remodeling, and inflammation related intratumoral responses. This service allows for rapid testing of 18 compounds at 4 concentrations for immuno-oncology potential in human tumor microenvironment models.

Organism:

Human

Assay Information

Assay Type:

Functional

Assay Sub Type:

Cell Based

Testing Information

Test Sample Requirements:

For Small Molecules, 50 ul of 1000X stock solution in 100% DMSO per agent. For Biologics, 500 ul of 100X stock solution in PBS or water per agent.

Minimum Order Quantity:

72

Turnaround Time

Standard:

30 Business Days

Clinical Relevance

Therapeutic Area:

Oncology/Immuno-Oncology

Additional Information

Brand:

BioMAP

Testing Location:

USA - St Charles, MO

RELATED SOLUTIONS

Item: 89-0003-0045
Item: 89-0015-0045
Item: 89-0044-0901
Item: 89-0047-0046
Item: HT2MP03
Item: HT2MP05
Item: HT2MP10
Item: HT2SP03
Item: HT2SP05
Item: HT2SP10
Item: HT2SP3D
Item: PSOP0001
Item: PSOP0002
Item: PSOP0003
Item: PSOP0010
Item: PSOP0011
Item: PSOP0012
Item: PSOP0013
Item: PSOP0014
Item: PSOP0015